Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.13
-0.0400-3.42%
Post-market: 1.130.0001+0.01%19:53 EDT
Volume:7.34M
Turnover:8.10M
Market Cap:247.14M
PE:-0.85
High:1.20
Open:1.20
Low:1.06
Close:1.17
Loading ...
Nov 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2022

Major Issues Report

8-K - Current report
Sep 21, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2022

Major Issues Report

8-K - Current report
Jun 17, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities